Abstract
A transforming gene isolated from T24 human bladder carcinoma cells is closely related to the BALB murine sarcoma virus (MSV) onc gene (v-bas). This transforming gene is localized to a 4.6 kilobase pair (kbp) region and is expressed as a 1.2-kbp polyadenylated transcript, which contains v-bas related sequences. Moreover, antisera known to detect the immunologically related onc gene products of BALB- and Harvey-MSVs recognized elevated levels of a related protein in T24 cells. The normal human homologue of v-bas was found to be indistinguishable from the T24 oncogene by heteroduplex and restriction enzyme analysis. These results imply that rather subtle genetic alterations have led to the activation of the normal human homologue of v-bas as a human transforming gene.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Cold Spring Harb. Symp. quant. Biol. 44, pt 2 (1980).
Frankel, A. E., Gilbert, J. H., Porzig, K. J., Scolnick, E. M. & Aaronson, S. A. J. Virol. 30, 821–827 (1979).
Shibuya, M., Hanafusa, T., Hanafusa, H. & Stephenson, J. R. Proc. natn. Acad. Sci. U.S.A. 77, 6536–6540 (1980).
Andersen, P. R. et al. Cell 26, 129–134 (1981).
Barbacid, M., Breitman, M. L., Lauver, A. L., Long, L. K. & Vogt, P. K. Virology 110, 411–419 (1981).
Beemon, K. Cell 24, 145–153 (1981).
Wang, L. H. et al. J. Virol. 40, 258–267 (1981).
Shih, C., Shilo, B. Z., Goldfarb, M. P., Dannenberg, A. & Weinberg, R. A. Proc. natn. Acad. Sci. U.S.A. 76, 5714–5718 (1979).
Cooper, G. M., Okenquist, S. & Silverman, L. Nature 284, 418–421 (1980).
Cooper, G. M. & Neiman, P. E. Nature 287, 656–659 (1980).
Hopkins, N., Besmer, P., DeLeo, A. B. & Law, L. W. Proc. natn. Acad. Sci. U.S.A. 78, 7555–7559 (1981).
Lane, M. A., Sainten, A. & Cooper, G. M. Proc. natn. Acad. Sci. U.S.A. 78, 5185–5189 (1981).
Shih, C., Padhy, C., Murray, M. & Weinberg, R. A. Nature 290, 261–264 (1981).
Krontikis, T. G. & Cooper, G. M. Proc. natn. Acad. Sci. U.S.A. 78, 1181–1184 (1981).
Murray, M. J. et al. Cell 25, 355–361 (1981).
Perucho, M. et al. Cell 27, 467–476 (1981).
Smith, B. L., Anisowicz, A., Chodosh, L. A. & Sager, R. Proc. natn. Acad. Sci. U.S.A. 79, 1964–1968 (1982).
Lane, M. A., Sainten, A. & Cooper, G. M. Cell 28, 873–880 (1982).
Pulciani, S. et al. Proc. natn. Acad. Sci. U.S.A. 79, 2845–2849 (1982).
Bubenik, J. et al. Int. J. Cancer 11, 765–773 (1973).
Marshall, C. J., Franks, L. M. & Carbonell, A. W. J. natn. Cancer Inst. 58, 1743–1747 (1977).
Goldfarb, M., Shimizu, K., Perucho, M. & Wigler, M. Nature 296, 404–409 (1982).
Shih, C. & Weinberg, R. A. Cell 29, 161–169 (1982).
Lautenberger, J. A., Schulz, R. A., Garon, C. F., Tsichlis, P. N. & Papas, T. S. Proc. natn. Acad. Sci. U.S.A. 78, 1518–1522 (1981).
Souza, L. M., Komaromy, M. C. & Baluda, M. A. Proc. natn. Acad. Sci. U.S.A. 77, 3004–3008 (1980).
Shalloway, D., Zelentz, A. D. & Cooper, G. M. Cell 24, 531–541 (1981).
Srinivasan, A., Reddy, E. P. & Aaronson, S. A. Proc. natn. Acad. Sci. U.S.A. 78, 2077–2081 (1981).
Vande Woude, G. F. et al. Proc. natn. Acad. Sci. U.S.A. 76, 4464–4468 (1979).
Tronick, S. R. et al. Proc. natn. Acad. Sci. U.S.A. 76, 6314–6318 (1979).
Sherr, C. J., Fedele, L. A., Oskarsson, M., Maizel, J. & Vande Woude, G. F. J. Virol. 34, 200–212 (1980).
Robbins, K. C., Devare, S. G. & Aaronson, S. A. Proc. natn. Acad. Sci. U.S.A. 78, 2918–2922 (1981).
Santos, E., Pulciani, S. & Barbacid, M. Fedn Proc. (in the press).
Eva, A. et al., Nature 295, 116–119 (1982).
Lawn, R. M., Fritsch, E. F., Parker, R. C., Blake, G. & Maniatis, T. Cell 15, 1157–1174 (1978).
Shih, T. Y., Weeks, M. O., Young, H. A. & Scolnick, E. M. Virology 96, 64–79 (1979).
Aaronson, S. A. & Todaro, G. J. Virology 36, 254–261 (1968).
Rasheed, S., Nelson-Rees, W. A., Toth, E. M., Arnstein, P. & Gardner, M. B. Cancer 33, 1027–1033 (1974).
Jainchill, J. L., Aaronson, S. A. & Todaro, G. J. J. Virol. 4, 549–553 (1969).
Peters, R. L., Rabstein, L. S., Van Vleck, R., Kelloff, G. J. & Huebner, R. J. J. natn. Cancer Inst. 53, 1725–1731 (1974).
Harvey, J. J. Nature 204, 1104–1107 (1964).
Scher, C. D., Scolnick, E. M. & Siegler, R. Nature 256, 225–228 (1975).
Southern, E. M. J. molec. Biol. 98, 503–517 (1975).
Davis, R. W., Simon, M. & Davidson, N. Meth. Enzym. 21, 413–428 (1971).
Cox, R. A. Meth. Enzym. 12, 120–129 (1967).
Aviv, H. & Leder, P. Proc. natn. Acad. Sci. U.S.A. 69, 1408–1412 (1972).
Bailey, J. M. & Davidson, N. Analyt. Biochem. 70, 75–85 (1976).
Barbacid, M., Lauver, A. L. & Devare, S. J. Virol. 33, 196–207 (1980).
Bonner, W. M. & Laskey, R. A. Eur. J. Biochem. 46, 83–88 (1974).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Santos, E., Tronick, S., Aaronson, S. et al. T24 human bladder carcinoma oncogene is an activated form of the normal human homologue of BALB- and Harvey-MSV transforming genes. Nature 298, 343–347 (1982). https://doi.org/10.1038/298343a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/298343a0
This article is cited by
-
The path to the clinic: a comprehensive review on direct KRASG12C inhibitors
Journal of Experimental & Clinical Cancer Research (2022)
-
The duality of human oncoproteins: drivers of cancer and congenital disorders
Nature Reviews Cancer (2020)
-
Short-term activation of the Jun N-terminal kinase pathway in apoptosis-deficient cells of Drosophila induces tumorigenesis
Nature Communications (2018)
-
Structural and functional characterization of a DARPin which inhibits Ras nucleotide exchange
Nature Communications (2017)
-
Direct small-molecule inhibitors of KRAS: from structural insights to mechanism-based design
Nature Reviews Drug Discovery (2016)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.